European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Oritavancin
[Marketwired] – The Medicines Company today announced that the European Medicines Agency has accepted for review a marketing authorization application for the investigational intravenous antibiotic, oritavancin, for the … moreView todays social media effects on MDCOView the latest stocks trending across Twitter. Click to view dashboardSee who The is hiring next, click here to view […]